Free Trial

EverQuote (NASDAQ:EVER) Stock Price Down 12.7% - Time to Sell?

EverQuote logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • EVER dropped 12.7% intraday to $20.80 with volume of 327,124 shares (about 65% below average); market cap ~$741M, 50‑day/200‑day moving averages $16.01/$20.82 and a PE of 7.0.
  • Quarterly results beat estimates — EPS $0.51 vs. $0.43 expected and revenue $190.85M vs. $180.1M, with revenue up 14.6% year‑over‑year, a 15.35% net margin and 56.58% ROE.
  • Analyst and ownership mix: consensus is a "Moderate Buy" (six Buys, two Holds) with an average price target of $24.17; insiders have recently sold shares (insider ownership ~25.5%) while institutions own ~91.5%.
  • MarketBeat previews top five stocks to own in June.

EverQuote, Inc. (NASDAQ:EVER - Get Free Report)'s stock price traded down 12.7% on Wednesday . The stock traded as low as $20.89 and last traded at $20.8040. 327,124 shares changed hands during mid-day trading, a decline of 65% from the average session volume of 933,243 shares. The stock had previously closed at $23.82.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Weiss Ratings cut shares of EverQuote from a "hold (c)" rating to a "hold (c-)" rating in a research note on Friday. B. Riley Financial lowered their price objective on shares of EverQuote from $36.00 to $30.00 and set a "buy" rating on the stock in a research note on Tuesday, February 24th. JPMorgan Chase & Co. increased their price objective on shares of EverQuote from $22.00 to $24.00 and gave the stock an "overweight" rating in a research note on Tuesday. Needham & Company LLC reiterated a "buy" rating and issued a $25.00 price objective on shares of EverQuote in a research note on Tuesday. Finally, Wall Street Zen cut shares of EverQuote from a "strong-buy" rating to a "buy" rating in a research note on Saturday, April 4th. Six investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, EverQuote currently has a consensus rating of "Moderate Buy" and an average price target of $24.17.

View Our Latest Research Report on EverQuote

EverQuote Stock Performance

The company's fifty day moving average is $16.01 and its 200-day moving average is $20.82. The company has a market capitalization of $741.14 million, a PE ratio of 7.00 and a beta of 0.56.

EverQuote (NASDAQ:EVER - Get Free Report) last released its earnings results on Monday, May 4th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.08. The company had revenue of $190.85 million during the quarter, compared to analyst estimates of $180.10 million. EverQuote had a net margin of 15.35% and a return on equity of 56.58%. The firm's quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.21 EPS. On average, sell-side analysts expect that EverQuote, Inc. will post 1.91 EPS for the current fiscal year.

Insider Activity at EverQuote

In related news, CEO Jayme Mendal sold 14,360 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $14.98, for a total value of $215,112.80. Following the completion of the sale, the chief executive officer directly owned 541,777 shares of the company's stock, valued at approximately $8,115,819.46. This represents a 2.58% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Jon Ayotte sold 1,730 shares of the stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $15.56, for a total transaction of $26,918.80. Following the completion of the sale, the chief accounting officer directly owned 86,202 shares of the company's stock, valued at $1,341,303.12. This represents a 1.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 18,095 shares of company stock valued at $272,489 over the last three months. 25.52% of the stock is currently owned by insiders.

Institutional Investors Weigh In On EverQuote

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Comerica Bank grew its holdings in EverQuote by 235.4% during the 3rd quarter. Comerica Bank now owns 1,100 shares of the company's stock valued at $25,000 after buying an additional 772 shares in the last quarter. Versant Capital Management Inc grew its holdings in EverQuote by 108.9% during the 3rd quarter. Versant Capital Management Inc now owns 1,153 shares of the company's stock valued at $26,000 after buying an additional 601 shares in the last quarter. NewEdge Advisors LLC purchased a new stake in EverQuote during the 3rd quarter valued at approximately $52,000. Clearstead Advisors LLC grew its holdings in EverQuote by 70.5% during the 4th quarter. Clearstead Advisors LLC now owns 1,997 shares of the company's stock valued at $54,000 after buying an additional 826 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its holdings in EverQuote by 595.8% during the 3rd quarter. Jones Financial Companies Lllp now owns 2,623 shares of the company's stock valued at $62,000 after buying an additional 2,246 shares in the last quarter. 91.54% of the stock is owned by hedge funds and other institutional investors.

About EverQuote

(Get Free Report)

EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.

The company's core business centers on a quote-comparison engine for personal auto, home, and health insurance products.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EverQuote Right Now?

Before you consider EverQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.

While EverQuote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines